| Eröffnung: | - |
| Veränderung: | - |
| Volumen: | - |
| Tief: | - |
| Hoch: | - |
| Hoch - Tief: | - |
| Typ: | Aktien |
| Ticker: | JNJ |
| ISIN: |
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
- 42
PR Newswire
NEW BRUNSWICK, N.J., April 20, 2022
NEW BRUNSWICK, N.J., April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48 hours after the live webcast.
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-ubs-global-healthcare-conference-301529498.html
SOURCE Johnson & Johnson
